ZEALAND PHARMA A/S revenue breakdown overview

ZEALAND PHARMA A/S revenue for the last year amounted to 8.42 M EUR, the most of which — 8.38 M EUR — came from its highest performing source at the moment, Peptide-based Medicines, the year earlier bringing 45.97 M EUR. The greatest contribution to the revenue figure was made by Denmark — last year it brought ZEALAND PHARMA A/S 8.33 M EUR, and the year before that — 5.93 M EUR.